Menopausal hormone therapy: Making sense of current guidelines

Emerging evidence confirms that menopausal hormone therapy (MHT) remains the most effective treatment for managing vasomotor and genitourinary symptoms of menopause, with a favorable risk-benefit profile in specific patient populations. Recent studies also indicate that initiating MHT in appropriate candidates is associated with reduced cardiovascular disease risk and lower all-cause mortality. This article provides a comprehensive overview of current guidelines for primary care providers, advocating for an evidence-based, patient-centered approach to enhancing menopausal care across diverse patient populations.